Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2012, Article ID 639342, 9 pages
http://dx.doi.org/10.1155/2012/639342
Research Article

Macrophage Migration Inhibitory Factor in Fetoplacental Tissues from Preeclamptic Pregnancies with or without Fetal Growth Restriction

1Department of Obstetrics and Gynecology, University of Turin, Sant’Anna Hospital, Via Ventimiglia 3, 10126 Torino, Italy
2Department of Physiology, University of Siena, Via Aldo Moro 4 53100 Siena, Italy
3Department of Molecular Pathology and Innovative Therapies, Marche Polytechnic University, Via Tronto 10/a 60020 Ancona, Italy

Received 24 May 2011; Revised 2 August 2011; Accepted 3 August 2011

Academic Editor: Gilbert Faure

Copyright © 2012 Simona Cardaropoli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. W. Redman and I. L. Sargent, “Latest advances in understanding preeclampsia,” Science, vol. 308, no. 5728, pp. 1592–1594, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. J. M. Roberts and H. S. Gammill, “Preeclampsia: recent insights,” Hypertension, vol. 46, no. 6, pp. 1243–1249, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. J. J. Walker, “Pre-eclampsia,” The Lancet, vol. 356, no. 9237, pp. 1260–1265, 2000. View at Google Scholar · View at Scopus
  4. F. Lyall, J. N. Bulmer, E. Duffie, F. Cousins, A. Theriault, and S. C. Robson, “Human trophoblast invasion and spiral artery transformation: the role of PECAM-1 in normal pregnancy, preeclampsia, and fetal growth restriction,” American Journal of Pathology, vol. 158, no. 5, pp. 1713–1721, 2001. View at Google Scholar · View at Scopus
  5. T. Calandra and T. Roger, “Macrophage migration inhibitory factor: a regulator of innate immunity,” Nature Reviews Immunology, vol. 3, no. 10, pp. 791–800, 2003. View at Google Scholar · View at Scopus
  6. S. I. Wada, S. I. Fujimoto, Y. Mizue, and J. Nishihira, “Macrophage migration inhibitory factor in the human ovary: presence in the follicular fluids and production by granulosa cells,” Biochemistry and Molecular Biology International, vol. 41, no. 4, pp. 805–814, 1997. View at Google Scholar · View at Scopus
  7. F. Arcuri, M. Cintorino, R. Vatti, A. Carducci, S. Liberatori, and L. Paulesu, “Expression of macrophage migration inhibitory factor transcript and protein by first-trimester human trophoblasts,” Biology of Reproduction, vol. 60, no. 6, pp. 1299–1303, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Arcuri, C. Ricci, F. Ietta et al., “Macrophage migration inhibitory factor in the human endometrium: expression and localization during the menstrual cycle and early pregnancy,” Biology of Reproduction, vol. 64, no. 4, pp. 1200–1205, 2001. View at Google Scholar · View at Scopus
  9. B. R. Bloom and B. Bennett, “Mechanism of a reaction in vitro associated with delayed-type hypersensitivity,” Science, vol. 153, no. 3731, pp. 80–82, 1966. View at Google Scholar · View at Scopus
  10. T. Calandra, J. Bernhagen, R. A. Mitchell, and R. Bucala, “The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor,” Journal of Experimental Medicine, vol. 179, no. 6, pp. 1895–1902, 1994. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Abe, T. Shimizu, A. Ohkawara, and J. Nishihira, “Enhancement of macrophage migration inhibitory factor (MIF) expression in injured epidermis and cultured fibroblasts,” Biochimica et Biophysica Acta, vol. 1500, no. 1, pp. 1–9, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Ietta, T. Todros, C. Ticconi et al., “Macrophage migration inhibitory factor in human pregnancy and labor,” American Journal of Reproductive Immunology, vol. 48, no. 6, pp. 404–409, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Calandra, J. Bernhagen, C. N. Metz et al., “MIF as a glucocorticoid-induced modulator of cytokine production,” Nature, vol. 377, no. 6544, pp. 68–71, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Todros, S. Bontempo, E. Piccoli et al., “Increased levels of macrophage migration inhibitory factor (MIF) in preeclampsia,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 123, no. 2, pp. 162–166, 2005. View at Publisher · View at Google Scholar
  15. “ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002,” Obstetrics & Gynecology, vol. 99, no. 1, pp. 159–167, 2002.
  16. S. A. Steel, J. M. Pearce, P. McParland, and G. V. P. Chamberlain, “Early doppler ultrasound screening in prediction of hypertensive disorders of pregnancy,” The Lancet, vol. 335, no. 8705, pp. 1548–1551, 1990. View at Publisher · View at Google Scholar · View at Scopus
  17. U. Nicolini, E. Ferrazzi, and R. Molla, “Accuracy of an average ultrasonic laboratory in measurements of fetal biparietal diameter, head circumference and abdominal circumference,” Journal of Perinatal Medicine, vol. 14, no. 2, pp. 101–107, 1986. View at Google Scholar · View at Scopus
  18. E. Bertino, E. Di Battista, A. Bossi et al., “Fetal growth velocity: kinetic, clinical, and biological aspects,” Archives of Disease in Childhood, vol. 74, no. 1, pp. F10–F15, 1996. View at Google Scholar · View at Scopus
  19. F. Parazzini, I. Cortinovis, R. Bortolus, and L. Fedele, “Standards of birth weight in Italy,” Annali di Ostetricia, Ginecologia, Medicina Perinatale, vol. 112, no. 4, pp. 203–246, 1991. View at Google Scholar
  20. T. Todros, G. Ronco, O. Fianchino et al., “Accuracy of the umbilical arteries Doppler flow velocity waveforms in detecting adverse perinatal outcomes in a high-risk population,” Acta Obstetricia et Gynecologica Scandinavica, vol. 75, no. 2, pp. 113–119, 1996. View at Google Scholar
  21. F. Y. Zeng, W. Y. Weiser, H. Kratzin, B. Stahl, M. Karas, and H. J. Gabius, “The major binding protein of the interferon antagonist sarcolectin in human placenta is a macrophage migration inhibitory factor,” Archives of Biochemistry and Biophysics, vol. 303, no. 1, pp. 74–80, 1993. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. X. Shan, Q. X. Lin, M. Yang et al., “Transcription factor Ap-1 mediates proangiogenic MIF expression in human endothelial cells exposed to Angiotensin II,” Cytokine, vol. 53, no. 1, pp. 35–41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. A. M. Isidori, G. A. Kaltsas, M. Korbonits et al., “Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 4, pp. 1834–1840, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Lorenzi, D. Marzioni, S. Giannubilo et al., “Expression patterns of two serine protease HtrA1 forms in human placentas complicated by preeclampsia with and without intrauterine growth restriction,” Placenta, vol. 30, no. 1, pp. 35–40, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Marzioni, T. Todros, S. Cardaropoli et al., “Activating protein-1 family of transcription factors in the human placenta complicated by preeclampsia with and without fetal growth restriction,” Placenta, vol. 31, no. 10, pp. 919–927, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Ornaghi, P. Vergani, G. Urban, V. Giardini, F. Moltrasio, and B. E. Leone, “Immunohistochemical expression of Annexin A5 in preeclamptic placentas,” Placenta, vol. 32, no. 3, pp. 264–268, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Eickhoff, G. Jennemann, G. Hoffbauer et al., “Immunohistochemical detection of macrophage migration inhibitory factor in fetal and adult bovine epididymis: release by the apocrine secretion mode?” Cells Tissues Organs, vol. 182, no. 1, pp. 22–31, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. K. L. Meyer-Siegler, E. C. Leifheit, and P. L. Vera, “Inhibition of macrophage migration inhibitory factor decreases proliferation and cytokine expression in bladder cancer cells,” BMC Cancer, vol. 4, article 34, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. P. L. Vera and K. L. Meyer-Siegler, “Inflammation of the rat prostate evokes release of macrophage migration inhibitory factor in the bladder: evidence for a viscerovisceral reflex,” Journal of Urology, vol. 172, no. 6 I, pp. 2440–2445, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. U. Arndt, G. Wennemuth, P. Barth et al., “Release of macrophage migration inhibitory factor and CXCL8/interleukin-8 from lung epithelial cells rendered necrotic by influenza A virus infection,” Journal of Virology, vol. 76, no. 18, pp. 9298–9306, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Ietta, Y. Wu, R. Romagnoli et al., “Oxygen regulation of macrophage migration inhibitory factor in human placenta,” American Journal of Physiology, vol. 292, no. 1, pp. E272–E280, 2007. View at Publisher · View at Google Scholar
  32. S. Chaisavaneeyakorn, N. Lucchi, C. Abramowsky et al., “Immunohistological characterization of macrophage migration inhibitory factor expression in Plasmodium falciparum-infected placentas,” Infection and Immunity, vol. 73, no. 6, pp. 3287–3293, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Zicari, C. Ticconi, F. Ietta et al., “Macrophage migration inhibitory factor-nitric oxide interaction in human fetal membranes at term pregnancy,” Journal of the Society for Gynecologic Investigation, vol. 13, no. 4, pp. 263–270, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Chaiworapongsa, R. Romero, J. Espinoza et al., “Macrophage migration inhibitory factor in patients with preterm parturition and microbial invasion of the amniotic cavity,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 18, no. 6, pp. 405–416, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. E. A. V. Ferro, J. R. Mineo, F. Ietta et al., “Macrophage migration inhibitory factor is up-regulated in human first-trimester placenta stimulated by soluble antigen of Toxoplasma gondii, resulting in increased monocyte adhesion on villous explants,” American Journal of Pathology, vol. 172, no. 1, pp. 50–58, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Roger, M. P. Glauser, and T. Calandra, “Macrophage migration inhibitory factor (MIF) modulates innate immune responses induced by endotoxin and Gram-negative bacteria,” Journal of Endotoxin Research, vol. 7, no. 6, pp. 456–460, 2001. View at Publisher · View at Google Scholar · View at Scopus